A detailed history of Gps Wealth Strategies Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 631 shares of REGN stock, worth $532,311. This represents 0.09% of its overall portfolio holdings.

Number of Shares
631
Previous 594 6.23%
Holding current value
$532,311
Previous $624,000 6.25%
% of portfolio
0.09%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$1024.09 - $1201.76 $37,891 - $44,465
37 Added 6.23%
631 $663,000
Q2 2024

Jul 16, 2024

BUY
$883.2 - $1071.19 $72,422 - $87,837
82 Added 16.02%
594 $624,000
Q1 2024

Apr 30, 2024

SELL
$902.69 - $993.35 $902 - $993
-1 Reduced 0.19%
512 $492,000
Q4 2023

Jan 12, 2024

BUY
$775.18 - $881.7 $54,262 - $61,719
70 Added 15.8%
513 $450,000
Q3 2023

Oct 25, 2023

BUY
$692.45 - $844.37 $24,235 - $29,552
35 Added 8.58%
443 $364,000
Q2 2023

Jul 17, 2023

BUY
$700.03 - $830.35 $107,104 - $127,043
153 Added 60.0%
408 $293,000
Q1 2023

Apr 17, 2023

BUY
$680.49 - $826.97 $173,524 - $210,877
255 New
255 $209,000
Q3 2022

Oct 17, 2022

SELL
$573.97 - $724.32 $1,147 - $1,448
-2 Reduced 0.87%
229 $158,000
Q2 2022

Jul 19, 2022

SELL
$548.35 - $738.84 $6,031 - $8,127
-11 Reduced 4.55%
231 $137,000
Q1 2022

Apr 20, 2022

BUY
$595.12 - $698.43 $11,307 - $13,270
19 Added 8.52%
242 $169,000
Q4 2021

Feb 11, 2022

BUY
$543.48 - $670.97 $14,673 - $18,116
27 Added 13.78%
223 $141,000
Q3 2021

Oct 20, 2021

BUY
$574.03 - $680.96 $36,737 - $43,581
64 Added 48.48%
196 $119,000
Q1 2021

Apr 15, 2021

BUY
$446.73 - $548.2 $58,968 - $72,362
132 New
132 $62,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $90.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Gps Wealth Strategies Group, LLC Portfolio

Follow Gps Wealth Strategies Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gps Wealth Strategies Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gps Wealth Strategies Group, LLC with notifications on news.